Tianyi Medical announced on the evening of June 5 that the company recently received the " Medical Device registration certificate involves two new products, namely a disposable continuous renal replacement therapy tube and a disposable hemodialysis tube.

According to the announcement, the disposable continuous renal replacement therapy tubing consists of tubing, threaded pre-filled needles, etc., and is used as a blood and fluid channel during continuous renal replacement therapy (CRRT); the disposable hemodialysis tubing consists of arterial tubes, venous tubes, etc., and is used as a blood channel for hemodialysis and hemodiafiltration mode treatment of patients with acute and chronic renal failure. Both products are sterilized with ethylene oxide and are disposable products.

According to information, Tianyi Medical is a high-tech enterprise mainly engaged in the research, development, production and sales of medical devices such as medical polymer consumables in the fields of blood purification and ward nursing. It is the first medical device company in China to obtain a registration certificate for CRRT-specific pipelines. Its extracorporeal blood circuit products currently have more than 200 specifications and models to meet diverse clinical needs such as different treatment modes, clinical usage habits and machine adaptability.

The company has a strong brand influence in the field of blood purification consumables. Its product sales cover 31 provinces, municipalities and autonomous regions in China, and its terminal hospitals cover more than 1,000 hospitals and 450 tertiary hospitals. At the same time, the company actively explores overseas markets, and its products are exported to countries and regions such as Asia, Europe, North America, South America, and Africa. It has accumulated a group of high-quality customer resources and has established a long-term cooperation with Fresenius Medical Care.We maintain good business cooperation relationships with leading international hemodialysis companies such as Baxter Healthcare and Nipro.

The announcement stated that the acquisition of this registration certificate will further enrich the product range, help improve market competitiveness and promote the company's development.

https://finance.eastmoney.com/a/202506053422966047.html